Nu-Med Plus (NUMD) Operating Leases (2019 - 2022)
Nu-Med Plus recorded quarterly Operating Leases of $2056.0 in Q2 2022, down 59.98% quarter-over-quarter from $5138.0 in Q1 2022, and up 3.06% year-over-year from $1995.0 in Q2 2021.
Nu-Med Plus' Operating Leases history runs 4 years deep, the most recent figure standing at $2056.0 for Q2 2022.
- In Q2 2022, Operating Leases rose 3.06% year-over-year to $2056.0; the TTM figure through Jun 2022 stood at $2056.0 (up 3.06% YoY), while the FY2021 annual figure was $8222.0, up 3.02% from the prior year.
- Operating Leases came in at $2056.0 for Q2 2022 at Nu-Med Plus, down from $5138.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $11647.0 in Q3 2021 to a low of $1995.0 in Q2 2021.
- A 4-year average of $6242.2 and a median of $5255.0 in 2020 frame the typical range for Operating Leases.
- Across the five-year window, Operating Leases grew 6.61% in 2020 and retreated 7.15% in 2021, its largest moves.
- Nu-Med Plus' Operating Leases stood at $8396.0 in 2019, then decreased by 4.94% to $7981.0 in 2020, then gained by 3.02% to $8222.0 in 2021, then sank by 74.99% to $2056.0 in 2022.
- According to Business Quant data, Operating Leases over the past three periods registered $2056.0, $5138.0, and $8222.0 for Q2 2022, Q1 2022, and Q4 2021 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nu-Med Plus | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 2,056.00 |
| Mar 31, 2022 | 5,138.00 |
| Dec 31, 2021 | 8,222.00 |
| Sep 30, 2021 | 11,647.00 |
| Jun 30, 2021 | 1,995.00 |
| Mar 31, 2021 | 4,988.00 |
| Dec 31, 2020 | 7,981.00 |
| Sep 30, 2020 | 10,975.00 |
| Jun 30, 2020 | 2,148.00 |
| Mar 31, 2020 | 5,372.00 |
| Dec 31, 2019 | 8,396.00 |
| Sep 30, 2019 | 11,418.00 |
| Jun 30, 2019 | 2,016.00 |
| Mar 31, 2019 | 5,039.00 |